Table 1.
Characteristics of study groups.
| Nontreated cells | Statins | Aspirin | Statin + aspirin | |
|---|---|---|---|---|
| Men (n) | 1504 | 440 | 160 | 304 |
| Age (years) | 67 | 68 | 68 | 67 |
| BMI (Kg/m2) | 26.9 | 27.6 | 27.2 | 27.8 |
| Serum PSA (ng/mL) | 6.9 | 6.7 | 6.9 | 6.8 |
| Positive DRE (%) | 540 (36) | 160 (36) | 50 (31) | 106 (35) |
| Gleason score < 7 (%) | 112 (7.4) | 32 (7.3) | 14 (8.8) | 18 (6) |
| Gleason score = 7 (%) | 273 (18.2) | 76 (17.3) | 38 (23.8) | 45 (14.8) |
| Gleason score > 7 (%) | 155 (10.3) | 43 (9.8) | 18 (11.2) | 24 (7.9) |
BMI: body mass index, PSA: prostate specific antigen, and DRE: digital rectal examination.